For over nine years, Franklin has been a beloved member of the Noll-Mcclintock family—a funny, smart, and playful 8-year-old rescue dog. Two years ago, Franklin faced a challenging diagnosis: an incurable cancer originating in his spleen. Determined to give Franklin the best possible care, his mom Chelsea Noll-Mcclintock, and his veterinary oncologist, Dr. Dorothy Girimonte from Haven Animal Health, turned to FidoCure for help.
Our platform offers an AI-driven precision medicine approach to canine cancer treatment. We analyze a dog's tumor and identify specific genetic mutations that can be targeted with precision therapies. These targeted treatments, originally developed for human cancer, have proven remarkably effective in treating canine cancer. Using advanced AI technology, we analyze the world's largest clinico-genomic database of canine cancer, comprising over 2 billion real-world data points, to identify the most suitable personalized therapies for each dog.
Our approach goes beyond cancer treatment, as every dog enrolled in our platform contributes to a growing database. This continuous collection of cancer data helps accelerate the development of new therapeutics for dogs, like Franklin, and potentially even humans facing cancer.
Franklin has been responding exceptionally well to his FidoCure-provided targeted therapy. Dr. Girimonte recently examined him and reported, "Franklin is doing great with no evidence of disease. His mom reports he's still playing with his toys, and he loves getting treats at his recheck visits."
We are thrilled that Franklin is thriving and enjoying more quality time with his family. Stories like Franklin's are the very reason we do what we do at FidoCure. We remain committed to helping more dogs facing cancer continue living happy, healthy lives.